Last reviewed · How we verify
Placebo for Levothyroxine
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
A placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect. Used for Control arm in levothyroxine efficacy and safety trial.
At a glance
| Generic name | Placebo for Levothyroxine |
|---|---|
| Sponsor | The George Washington University Biostatistics Center |
| Modality | Small molecule |
| Therapeutic area | Endocrinology |
| Phase | Phase 3 |
Mechanism of action
Placebos are inert substances used as controls in clinical trials to establish the efficacy of an active drug by comparison. Any observed effects in placebo groups are attributed to the placebo effect (psychological and contextual factors) rather than direct drug action. In this Phase 3 trial, the placebo serves as a comparator to levothyroxine, a thyroid hormone replacement therapy.
Approved indications
- Control arm in levothyroxine efficacy and safety trial
Common side effects
Key clinical trials
- Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans (PHASE2)
- Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity. (PHASE3)
- Role of Levothyroxine Supplementation in Delayed Recovery Following Cardiac Surgery (PHASE3)
- A Clinical Trial of Adjunctive Thyroxine for Avolition in Schizophrenia (EARLY_PHASE1)
- LIGHT Trial: Levothyroxine for Gestational Hypothyroidism in Recurrent Pregnancy Loss (PHASE3)
- Levothyroxine Supplementation for Heart Transplant Recipients (PHASE1)
- Developing Oral LT3 Therapy for Heart Failure - HFpEF (PHASE1, PHASE2)
- Developing Oral LT3 Therapy for Heart Failure - HFrEF (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: